Journal
JOURNAL OF APPLIED MICROBIOLOGY
Volume 131, Issue 4, Pages 1578-1599Publisher
OXFORD UNIV PRESS
DOI: 10.1111/jam.15088
Keywords
anti‐ mycobacterial activity; bioactive molecules; ethnomedicinal plants; immunotherapy; preclinical trial; tuberculosis
Categories
Funding
- DST-SERB [SRG/2020/001922]
- SOA Deemed to be University
Ask authors/readers for more resources
Tuberculosis is a deadly infectious disease affecting approximately one-third of the global population, with the discovery of anti-TB antibiotics initially reducing the death rate. However, the emergence of antibiotic-resistant strains of the TB pathogen and resurgence of immune-compromised diseases have raised mortality rates again. WHO has warned of a potential pandemic situation in TB-endemic countries until the discovery of new anti-tubercular drugs is made.
Tuberculosis (TB) is one of the deadliest infectious diseases of human civilization. Approximately one-third of global population is latently infected with the TB pathogen Mycobacterium tuberculosis (M.tb). The discovery of anti-TB antibiotics leads to decline in death rate of TB. However, the evolution of antibiotic-resistant M.tb-strain and the resurgence of different immune-compromised diseases re-escalated the death rate of TB. WHO has already cautioned about the chances of pandemic situation in TB endemic countries until the discovery of new anti-tubercular drugs, that is, the need of the hour. Analysing the pathogenesis of TB, it was found that M.tb evades the host by altering the balance of immune response and affects either by killing the cells or by creating inflammation. In the pre-antibiotic era, traditional medicines were only therapeutic measures for different infectious diseases including tuberculosis. The ancient literatures of India or ample Indian traditional knowledge and ethnomedicinal practices are evidence for the treatment of TB using different indigenous plants. However, in the light of modern scientific approach, anti-TB effects of those plants and their bioactive molecules were not established thoroughly. In this review, focus has been given on five bioactive molecules of different traditionally used Indian ethnomedicinal plants for treatment of TB or TB-like symptom. These compounds are also validated with proper identification and their mode of action with modern scientific approaches. The effectiveness of these molecules for sensitive or drug-resistant TB pathogen in clinical or preclinical studies was also evaluated. Thus, our specific aim is to highlight such scientifically validated bioactive compounds having anti-mycobacterial and immunomodulatory activity for future use as medicine or adjunct-therapeutic molecule for TB management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available